"On behalf of the Board, I would like to thank Catarina for the good work she has done at Dignitana.Among other things, she has been a valuable contributor to the development of Dignitana's strategic plan and a driving force in creating a strong governance structure, which ultimately has created a solid foundation for continued growth and profitability.We wish her all the best in her future career,"comments Klas Arildsson, Chairman of the Board.

"I appreciate the time that I have spent at Dignitana and wish the company and my successor all the best as Dignitana continues to grow," says Catarina Mård Löwenadler, CEO of Dignitana.

Fredrik Jonsson, who assumes the role of CEO on 2 May 2024, is an accomplished leader with a focus on entrepreneurship, sales, marketing, and strategy. With extensive experience in both large and small MedTech organizations, Fredrik brings valuable expertise to the Company. He comes most recently from the role as CEO of Spotlight-listed Alteco Medical AB, was previously CEO of Distributed Medical AB, and has held senior positions in companies operating in the fields of endoscopy and dentistry.

"I take on the role as CEO of Dignitana with humility, as it is an assignment with great responsibility and the opportunity to positively impact the lives of cancer patients at a critical time in their treatment. I look forward to helping the team deliver on Dignitana's strategic priorities in my new role," says Fredrik Jonsson.

"We are pleased that Fredrik has chosen to join Dignitana as CEO to lead the company in our continued development toward profitability," adds Klas Arildsson, Chairman of the Board.

This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 24-04-2024 18:03 CET.